Most Recent
ABC, Fairfax can’t alter defence in Chau Chak Wing defamation case
The ABC and Fairfax have lost their bid to file an amended defence in defamation proceedings brought by Chinese businessman Chau Chak Wing, several months after the Full Federal Court upheld a ruling striking out out the publishers' truth defence.
Uber Eats driver fired for being 10 minutes late brings appeal
An Uber Eats driver who was allegedly sacked for being ten minutes late is appealing the Fair Work Commission's dismissal of her case.
Fortescue launches High Court appeal to native title ruling
Mining giant Fortescue Metals is seeking special leave from the High Court to appeal a ruling that granted native title to the Yinjibarndi people over a large section of land in the Pilbara region of Western Australia.
Part of K&L Gates’ employment team strikes out on its own
A sizeable group of employment lawyers from K&L Gates has parted ways with the US legal giant to set up its own specialist shop, shaking up the market for employment law services in Australia.
$2.5M break fee in Pacific Energy takeover battle not anti-competitive, panel says
The Takeovers Panel has found that while a $2.5 million break fee included in a $470 million takeover offer lobbed during a bidding war for Western Australia power supplier Pacific Energy was not a "common market approach", it was not anti-competitive or coercive.
Monster Energy takes on ‘mother’ of a trade mark battle
Monster Energy has launched another Federal Court case against Vittoria Food & Beverage seeking to block the coffee maker from trading on the popularity of its Mother energy drink brand, and the beverage giant will have to convince the court that its brand is not so strong that confusion among consumers is not likely.
Cap Coast Telecoms pre-insolvency advisor gets jail time for money laundering
A former pre-insolvency advisor has been sentenced to four and half years in prison for siphoning money from defunct Telstra dealer Cap Coast Telecoms prior to it being voluntarily wound up.
Pfizer takes Sandoz to court for info on Enbrel biosimilar
Pfizer, maker of the blockbuster rheumatoid arthritis biologic Enbrel, has taken generic drug maker Sandoz to court for information on its Enbrel biosimilar, after winning a bid for preliminary discovery against Samsung Biopis to pursue a possible infringement case over the same drug.
Latest suit claims Macquarie owes $4.8M in underpayments
Macquarie Bank has been hit with another lawsuit by former financial advisers who claim the bank underpaid them to the tune of $4.8 million by remunerating them solely in commission when they were entitled to a regular wage.
Vocation class action lumbers on with pared claims
Certain claims in a shareholder class action against insolvent training company Vocation and auditor PricewaterhouseCoopers have been dropped, as the long-running case awaits a new trial date pending the outcome of a separate Full Court appeal.